Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
capecitabine (xeloda) (2 trials)
docetaxel (taxotere) (2 trials)
Breast Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)